Masthead

nForm Blog

Category: Q&A

Masthead

Oncology Q&A

Next Frontier in Cellular Therapy: A Q&A on Characterizing CAR-T Cells on a Grand Scale

In early June 2021, NanoString and the Parker Institute for Cancer Immunotherapy (PICI) announced a multi-center collaboration to characterize 800 CAR-T samples in a unique and concerted effort to understand…

Laura Tabellini Pierre / July 26, 2021
profiler 1

nCounter Q&A

CRO Spotlight: Invest in Today for a Better Tomorrow. A Chat with Oncocyte™ on Its Vision for a Disease-Free Future.

Oncocyte™ is a molecular diagnostic company located in Irvine, CA. It provides services aimed to accelerate and optimize the diagnosis and treatment of cancer with both patented tests and biopharma…

Laura Tabellini Pierre / June 14, 2021

Oncology Panels Q&A

A “Tail” of Two Species: New Canine Immuno-Oncology Research Offering.

NanoString has an unparalleled and longstanding tradition of developing best in class cancer research tools, thanks to an extensive knowledge accumulated in a decade of interrogating all aspects of the…

Laura Tabellini Pierre / March 1, 2021
Hollywood spotlight on a CRO.

Q&A Services and Core Labs

Vision, Cutting-Edge Technology, and Deep Expertise. Interview with the Scientists at Propath UK, the Royals Among the CROs.

A few years ago, the UK Prime Minister’s office announced that Propath, a trusted specialist in molecular pathology for biopharmaceutical research and development, had been nominated to receive a Queen’s…

Laura Tabellini Pierre / November 2, 2020
Hollywood spotlight on a CRO.

Q&A

ROSALIND® by OnRamp Bio: A new platform for nCounter® expression analysis.

Recently NanoString® has announced its partnership with OnRamp Bioinformatics, a provider of cloud-based genomic analysis tools, to integrate our knowledge and expertise into an optimized analysis experience for nCounter with…

Elizabeth Schneider / October 19, 2020
Coffee blue background

Q&A Services and Core Labs

Serotonin, Gut-Brain-Microbiome Axis and an Inspired Young Scientist. How a Core Facility is Born. Q&A with Prof. Beate Niesler, Institute of Human Genetics, University of Heidelberg, Germany.

Imagine you are setting up for an interview with a prominent professor at the University of Heidelberg in Germany, in which you will focus on how a scientific interest triggered…

Laura Tabellini Pierre / September 14, 2020
Background with hearts, lungs and kidneys

Grants Q&A Transplant

Molecular Signatures of Antibody-Mediated Rejection and Graft Outcome After Kidney Transplantation. Q&A with Dr. Dela Golshayan, M.D., Ph.D.

When Newsweek Magazine rates you the 9th best Hospital in the World, you know you are doing something remarkable!  Located in Lausanne, Switzerland, Lausanne University Hospital (CHUV) sits on Lake Geneva…

Laura Tabellini Pierre / August 31, 2020
Blue background showing lab materials

Grants Q&A

All Things Grants. Q&A with a Grant Reviewer and two Grant Writers – Tips & Tricks for Success.

“An advice I would give to a beginner grant writer is to take the reviewer by hand, take him one step at the time in a logical fashion through that…

Laura Tabellini Pierre / August 17, 2020
Coffee blue background

Digital Spatial Profiling Q&A Services and Core Labs

Excellence, Cooperation, and Passion Come Together to Serve the Scientific Community. Q&A with Dr. Peter O’Toole, Director of the Bioscience Technology Facility, University of York.

Dr. Peter O’Toole, Ph.D., is the director of the Bioscience Technology Facility at the University of York in England, where he established and still leads the Imaging and Cytometry Laboratory, one of the…

Laura Tabellini Pierre / August 3, 2020
blue background of cancerous cells

Oncology Panels Q&A

Statistically Significant Results without the Headache. Q&A with Sarah Church, PhD, Senior Scientist at NanoString.

Talking to Sarah, whether during social gatherings or within the office walls, is always a pleasure. Dr. Church is a Senior Scientist at NanoString, and one of the warmest people…

Laura Tabellini Pierre / July 27, 2020
Hollywood spotlight on a CRO.

Panels Q&A Services and Core Labs

Spotlight on a CRO: Interview with the Team of Scientists behind NeoGenomics Pharma Services.

NeoGenomics is a cancer diagnostics and pharma services company serving pharmaceutical companies and academic centers. They specialize in diagnostic, prognostic and predictive testing using the most innovative technologies. The company…

Laura Tabellini Pierre / July 8, 2020
blue background of cancerous cells

Oncology Q&A

Going Beyond PDL-1. Q&A with Dr. Nina Radosevic- Robin, MD.

Dr. Nina Radosevic-Robin, MD, is a Board-Certified Surgical/Molecular Pathologist at Centre Jean Perrin, a Sr. Scientist within the Unit 1240 of French National Institute for Medical Research (INSERM), and a…

Laura Tabellini Pierre / June 22, 2020